You are here: Industry Insights > Aetion

News List

FDA Selects Aetion Evidence Platform® to Advance Regulatory Science and Innovation prnewswire
October 22, 2021
Today, Aetion announces that it is expanding its relationship with the U.S. Food and Drug Administration (FDA) to use real-world evidence (RWE) to study COVID-19 interventions and advance regulatory science and innovation.
Syneos Health, Aetion Partner on Regulatory-grade Data, Analytics Solutions contractpharma
August 05, 2021
Combines Syneos’ data collection and research services with Aetion Evidence Platform to generate evidence through patient data curation and real-world data.
Aetion and Cegedim expand real-world data partnership pharmatimes
July 14, 2021
Aetion and Cegedim Health Data have expanded their collaboration with a new three-year partnership focused on facilitating access to Cegedim’s anonymised real-world data through Aetion’s evidence platform.
Aetion Statement on UCSF-Led Study to Inform Drug Development for COVID-19, Future Pandemics prnewswire
October 16, 2020
Aetion co-authored a study published in Science, which examined lethal coronaviruses SARS-CoV-2, SARS-CoV-1, and MERS-CoV to identify molecular characteristics of potential treatments.